Cargando…
G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis
This study screened large cohorts of node-positive and node-negative breast cancer patients to determine whether the G388R mutation of the FGFR4 gene is a useful prognostic marker for breast cancer as reported by Bange et al in 2002. Node-positive (n=139) and node-negative (n=95) breast cancer cohor...
Autores principales: | Jézéquel, P, Campion, L, Joalland, M-P, Millour, M, Dravet, F, Classe, J-M, Delecroix, V, Deporte, R, Fumoleau, P, Ricolleau, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395301/ https://www.ncbi.nlm.nih.gov/pubmed/14710228 http://dx.doi.org/10.1038/sj.bjc.6601450 |
Ejemplares similares
-
FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells
por: Sturla, L-M, et al.
Publicado: (2003) -
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis
por: Matakidou, A, et al.
Publicado: (2007) -
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
por: Streit, S, et al.
Publicado: (2006) -
Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma
por: Kallio, J P, et al.
Publicado: (2003) -
Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis
por: Tebeu, P-M, et al.
Publicado: (2004)